.AstraZeneca has shared an early consider the efficiency of its own in-house antibody-drug conjugate...
.After revealing a period 3 launch based on beneficial midstage outcomes, iTeos and GSK are actually...
.The FDA ought to be more open as well as collective to discharge a rise in commendations of rare ai...
.It's an unusually hectic Friday for biotech IPOs, with Zenas BioPharma, MBX as well as Bicara Rehab...
.Atea Pharmaceuticals' antiviral has failed an additional COVID-19 trial, however the biotech still ...
.Neurocrine Biosciences' mental illness program pivot has actually stopped working. The biotech was ...
.Sanofi has actually created a late access to the radioligand gathering, paying for one hundred thou...
.After F2G's initial attempt to receive a new training class of antifungal to market was thwarted du...
.Moderna has vowed to reduce R&D spending by $1.1 billion through 2027. The selection to shrink t...
.Merely 4 months after Sanofi bet $80 million in beforehand cash money on Key Therapeutics' losmapim...